Efficacy of Early Pegylated Interferon α-2b Monotherapy for Acute Hepatitis C in HIV-Infected Patients

被引：3
|
作者：
De Rosa, Francesco G. [1 ]
Mollaretti, Oscar [1 ]
Audagnotto, Sabrina [1 ]
De Blasi, Tiziano [1 ]
Cariti, Giuseppe [1 ]
Marucco, Diego M. Aguilar [1 ]
Bonora, Stefano [1 ]
Di Perri, Giovanni [1 ]
机构：
[1] Osped Amedeo di Savoia, Dept Infect Dis, Turin, Italy
来源：
CLINICAL INFECTIOUS DISEASES | 2009年 / 48卷 / 11期
关键词：
VIRUS;
D O I：
10.1086/598995
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1636 / 1637
页数：2
相关论文
共 50 条
  • [21] Pegylated interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.
    Garcia-Samaniego, J
    Romero, M
    Pérez-Olmeda, M
    Barreiro, P
    Nuñez, M
    Soriano, V
    HEPATOLOGY, 2001, 34 (04) : 580A - 580A
  • [22] Autoimmune hepatitis induced by pegylated interferon in an HIV-infected patient with chronic hepatitis C
    Vispo, Eugenia
    Maida, Ivana
    Moreno, Alberto
    Barreiro, Pablo
    Soriano, Vincent
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (06) : 1470 - 1472
  • [23] The comparison of the efficacy of pegylated interferon α-2a and α-2b in chronic hepatitis B patients
    Dogan, Umit B.
    Golge, Necmettin
    Akin, Mustafa S.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (11) : 1312 - 1316
  • [24] Response to interferon alpha 2B plus ribavirin in hepatitis C infected patients who failed interferon alpha 2B monotherapy.
    King, JW
    Favrot, DR
    Shakhashiro, A
    Gholson, CF
    Balart, LA
    Achord, J
    Kirkikis, JA
    Lyles, WE
    Hollier, JD
    Srinivas, D
    HEPATOLOGY, 1998, 28 (04) : 708A - 708A
  • [25] Therapy with pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C.
    Romero, M
    Nunez, M
    Perez-Olmeda, M
    Gonzalez, J
    Castro, A
    Arribas, JR
    Barreiro, P
    Soriano, V
    Garcia-Samaniego, J
    HEPATOLOGY, 2002, 36 (04) : 363A - 363A
  • [26] Pegylated interferon alpha 2b (PEG-IFN) plus ribavirin (RBV) versus pegylated interferon alpha 2b for chronic hepatitis C in HIV patients
    Cargnel, A
    Angeli, E
    Mainini, A
    Gubertini, G
    Giorgi, R
    Orlando, G
    Duca, P
    GASTROENTEROLOGY, 2003, 124 (04) : A766 - A766
  • [27] The comparison of the efficacy of pegylated interferon α-2a and α-2b in chronic hepatitis C patients with genotype 1
    Dogan, Umit B.
    Atabay, Ayse
    Akin, Mustafa S.
    Yalaki, Serkan
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (09) : 1082 - 1085
  • [28] Pegylated Interferon Alfa-2a Monotherapy for Hemodialysis Patients with Acute Hepatitis C
    Liu, Chen-Hua
    Liang, Cheng-Chao
    Liu, Chun-Jen
    Lin, Jou-Wei
    Chen, Shih-I
    Hung, Peir-Haur
    Tsai, Hung-Bin
    Lai, Ming-Yang
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Kao, Jia-Horng
    CLINICAL INFECTIOUS DISEASES, 2010, 51 (05) : 541 - 549
  • [29] PEGYLATED INTERFERON ALFA-2A MONOTHERAPY FOR HEMODIALYSIS PATIENTS WITH ACUTE HEPATITIS C
    Liu, Chen-Hua
    Liang, Cheng-Chao
    Liu, Chun-Jen
    Hsu, Shih-Jer
    Chen, Shih-I
    Tsai, Hung-Bin
    Hung, Peir-Haur
    Lin, Jou-Wei
    Lai, Ming-Yang
    Chen, Pei-Jer
    Chen, Jun-Herng
    Chen, Ding-Shinn
    Kao, Jia-Horng
    HEPATOLOGY, 2009, 50 (04) : 692A - 692A
  • [30] 24 weeks of monotherapy with pegylated interferon alfa-2b in patients with acute hepatitis C.
    Wiegand, J
    Boecher, W
    Buggisch, P
    Zeuzem, S
    Gelbmann, CM
    Cornberg, M
    Jäckel, E
    Wedemeyer, H
    Manus, MP
    HEPATOLOGY, 2003, 38 (04) : 277A - 277A
12345